Skip to main content
Livermore
Livermore
ZHEN

LPL Financial LLC

SEC CIK
0001403438
Latest filing
Aug 7, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by LPL Financial LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2026)
5,615
Value
$392.0K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of NKTR by LPL Financial LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,615$392.0K<0.1%+1,065+23.4%AddedHolders
Q1 20264,550$327.4K<0.1%+4,550NewHolders
Q4 20250$00.0%−4,754−100.0%Sold outHolders
Q3 20254,754$270.5K<0.1%+4,754NewHolders
Q2 20250$00.0%−4,134−100.0%Sold outConverted for a 1-for-15 splitHolders
Q1 202562,012$42.2K<0.1%+815+1.3%AddedHolders
Q4 202461,197$56.9K<0.1%−4,553−6.9%ReducedHolders
Q3 202465,750$85.5K<0.1%+16,460+33.4%AddedHolders
Q2 202449,290$61.1K<0.1%+13,797+38.9%AddedHolders
Q1 202435,493$33.2K<0.1%−130.0%ReducedHolders
Q4 202335,506$20.1K<0.1%00.0%UnchangedHolders
Q3 202335,506$21.1K<0.1%+25,100+241.2%AddedHolders
Q2 202310,406$5.99K<0.1%−50−0.5%ReducedHolders
Q1 202310,456$7.35K<0.1%+29+0.3%AddedHolders
Q4 202210,427$23.6K<0.1%−10,550−50.3%ReducedHolders
Q3 202220,977$67.0K<0.1%+159+0.8%AddedHolders
Q2 202220,818$79.0K<0.1%−11,151−34.9%ReducedHolders
Q1 202231,969$172.0K<0.1%−798−2.4%ReducedHolders
Q4 202132,767$443.0K<0.1%+1,935+6.3%AddedHolders
Q3 202130,832$554.0K<0.1%−1,300−4.0%ReducedHolders
Q2 202132,132$551.0K<0.1%+637+2.0%AddedHolders
Q1 202131,495$630.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.